PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

12 Life Sciences Trends to Look Forward to 2018

Master Data Management 2.0

Compliance Information at a Click

Top Story

Drug Pricing Dominates Senate Hearing on HHS Nominee Azar

After yesterday's approval of Alex Azar's nomination as Department of Health and Human Services (HHS) secretary, Jill Wechsler looks at his recent comments on drug pricing
… /Read more/

Regulatory Information Management Best Practices
Read this Executive Summary to learn how to reduce regulatory complexity, ensure data quality and improve the user experience while ensuring compliance.

Download Now

Forecast

"Value" will Define the Next Year in Pharma

Cassandra Sinclair discusses how value plays a role in the shifting landscape for 2018
… /Read more/

The Rare Disease Revolution
Live Webcast: Thursday, January 25 11:00am EST

Forecast

Pharm Exec's 2018 Industry Forecast

In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry in 2018
… /Read more/

Maximizing Medical Affairs Impact through Strategic Alignment and Collaboration: Best Practice and Live Benchmarking
Live Webcast: Wednesday, January 24 at 11:00am EST

Marketing

Trigger Emails for Healthcare Marketing

Charles Benaiah highlights the benefits of a new IT favorite for healthcare marketing, trigger emails
… /Read more/

Risk Management

Understanding, Embracing, and Aligning on Risks in Outcomes-Based Contracts

Shared understanding of both risks and benefits to all parties in the healthcare continuum is essential in order to deliver more value, write Vickie Andros and Jake Caines
… /Read more/

Pharma Pricing & Market Access Congress 2018
20-21 March 2018 Business Design Centre
Join 400+ senior executives from pharma pricing, market access, value & evidence!

Visit Website to find out more

Calendar

/ January 23–24: 13^th Biosimilars Summit /

Alexandria, VA

/ January 24–25: Reimbursement and Contracting /

Philadelphia, PA

/ February 7–8: Speaker Programs 2018 /

Philadelphia, PA

/ March 19–22: DCAT Week '18 /

New York, NY

/ March 25–28: 14^th Annual Pharma Forum /

Philadelphia, PA

/ March 28–29: Expanded Access Programs /

Washington, DC

/ April 10–12: LogiPharma 2018 /

Montreux, Switzerland

/ April 11–12: 8^th Annual Global Transparency Reporting Congress /

London, UK

/ May 10–11: Pharma Marketing Summit /

Palm Beach, FL

/ October 15–17: 28^th Annual Sharing Conference: Compliance /

National Harbor, MD

Industry update

// Astellas (Northbrook, IL) announced that Steve Sabus was appointed General Manager of Astellas Pharma Canada, and Lynn Fenicchia Gerber and Kevin O'Keefe were promoted to new roles in the US sales organization. // Foamix Pharmaceuticals (Rehovot, Israel and Bridewater, NJ) named David Domzalski as a Member of the Board. // Pacira Pharmaceuticals (Parsippany, NJ) appointed Scott Braunstein, MD, as Chief Operating Officer and Richard Scranton, MD, as Chief Scientific Officer. // HealthPrize Technologies (Norwalk, CT) appointed Michael A. Griffith as Executive Chairman. // Concept Life Sciences (Concept) appointed Helen McKeever as Program Manager for the Group, and David Halverson as US Head of Sales. // Dr. John F. Howes was named Vice President of Clinical and Regulatory Affairs of Regentys (Miami Lakes, FL). //

advertise with us / print subscribe / digital subscribe / visit pharmexec.com